Shift Bioscience CEO and founder Daniel Ives (L) at the startup's headquarters in Cambridge, UK
Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock
Seven years ago, Daniel Ives believed that he was on the cusp of solving aging. He wanted to continue working on a discovery he made …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
